Ameloblastoma and adenomatoid odontogenic tumor: the role of α2β1, α3β1, and α5β1 integrins in local invasiveness and architectural characteristics

Annals of Diagnostic Pathology

Volumn 11, Issue 3, 2007, Pages 199-205

  Souza Andrade, Emanuel Sávio ^a   da Costa Miguel, Márcia Cristina ^b   Pinto, Leão Pereira ^b   de Souza, Lélia Batista ^b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Adenomatoid odontogenic tumor; Ameloblastoma; Integrins

Indexed keywords

PARAFFIN; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 3; VERY LATE ACTIVATION ANTIGEN 5;

ADENOMATOID TUMOR; AMELOBLASTOMA; ANTIGEN EXPRESSION; ARTICLE; BASAL CELL; CANCER INVASION; CELL INVASION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; MORPHOLOGICAL TRAIT; MOUSE; NONHUMAN; ODONTOGENIC TUMOR; OVARY FOLLICLE CELL; PRIORITY JOURNAL; SOLID TUMOR; STATISTICAL SIGNIFICANCE;

AMELOBLASTOMA; CELL COMMUNICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN ALPHA2BETA1; INTEGRIN ALPHA3BETA1; INTEGRIN ALPHA5BETA1; JAW NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; ODONTOGENIC TUMORS;

EID: 34247860843     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2006.04.005     Document Type: Article

References (38)

1. Waldron C.A. Odontogenic cysts and tumors. In: Neville B.W., Damm D.D., Allen C.M., et al. (Eds). Oral and maxillofacial pathology (2002), Saunders, Philadelphia 610-611
2. Melrose R.J. Benign epithelial odontogenic tumors. Semin Diagn Pathol 16 (1999) 271-287
3. Santos J.N., Pereira Pinto L., Figueredo C.R.L.V., et al. Odontogenic tumors: analysis of 127 cases. Pesqui Odontol Bras 15 (2001) 308-313
4. Philipsen H.P., and Reichart P.A. Unicystic ameloblastoma. A review of 193 cases from the literature. Oral Oncol 34 (1998) 317-325
5. Reichart P.A., Philipsen H.P., and Sonner S. Ameloblastoma: biological profile of 3677 cases. Oral Oncol 31B (1995) 86-99
6. Mosqueda-Taylor A., Ledesma-Montes C., Caballero-Sandoval S., et al. Odontogenic tumors in Mexico. A collaborative retrospective study of 349 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 48 (1997) 672-675
7. Heikinheimo K., Morgan P.R., Happonen R.P., et al. Distribution of extracellular matrix proteins in odontogenic tumours and developing teeth. Virchows Arch B Cell Pathol 61 (1991) 101-109
8. Medeiros AMC. Expressão da fibronectina, tenascina e colágeno I em ameloblastomas e no tumor odontogênico adenomatóide. Tese (Doutorado em Patologia Oral). Departamento de Odontologia. Universidade Federal do Rio Grande do Norte. Natal-RN: 2001. 125p.
9. Yokosaki Y., Monis H., Chen J., et al. Differential effects of the integrins α9β1, αvβ3, and αvβ6 on cell proliferative response to tenascin. Roles of the β subunit extracellular and cytoplasmic domains. J Biol Chem 271 (1996) 24144-24150
10. Miles A.J., Knutson J.R., Skubitz A.P., et al. A peptide model of basement membrane collagen α1 (IV) 531-543 binds the α3β1 integrin. J Biol Chem 270 (1995) 29047-29050
11. Van Waes C., Surh D.M., Chen Z., et al. Increase in suprabasilar integrin adhesion molecule expression in human epidermal neoplasms accompanies increased proliferation occurring with immortalization and tumor progression. Cancer Res 55 (1995) 5434-5444
12. Franchi A., Santoro R., Paglierani M., et al. Comparison of integrin α chain expression in benign and malignant salivary gland tumours. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83 (1997) 588-595
13. Benassi M.S., Ragazzini P., Gamberi G., et al. Adhesion molecules in high-grade soft tissue sarcomas: correlation to clinical outcome. Eur J Cancer 34 (1998) 496-502
14. Hynes R.O. Integrins: a family of cell surface receptors. Cell 48 (1987) 549-554
15. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69 (1992) 11-25
16. Thomas G.J., Jones J., and Speight P.M. Integrins and oral cancer. Oral Oncol 33 (1997) 381-388
17. Coppolino M.G., and Deddhar S. Bi-directional signal transduction by integrin receptors. Int J Biochem Cell Biol 32 (2000) 171-188
18. Philipsen H.P., and Reichart P.A. Adenomatoid odontogenic tumour: facts and figures. Oral Oncol 35 (1998) 125-131
19. Kreidberg J.A. Functions of α3β1 integrin. Curr Opin Cell Biol 12 (2000) 548-555
20. Salo T., Kainulanen T., Parikka M., and Heikinheimo K. Expression of laminin-5 in ameloblastomas and human fetal teeth. J Oral Pathol Med 28 (1999) 337-342
21. Souza L.B., Sousa C.V.C., and Pereira Pinto L. Estudo morfológico e imuno-histoquímico da membrana basal em diversos padrões histológicos do ameloblastoma. RPG 8 (2001) 40-45
22. Di Persio C.M., Hodivala-Dilke K.M., Jaenish R., et al. α3β1 integrin is required for normal development of the epidermal basement membrane. J Cell Biol 137 (1997) 729-742
23. Romberger D.J. Molecules in focus. Fibronectin. Int J Biochem Cell Biol 29 (1997) 939-943
24. Labat-Robert J. Fibronectin in malignancy. Effect of aging. Semin Cancer Biol 12 (2002) 187-195
25. Pinheiro J.J.V., Freitas V.M., Jorge A.G., et al. Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity. Histopathology 45 (2004) 65-72
26. Kumamoto H., Yamauchi K., Yoshida M., et al. Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas. J Oral Pathol Med 32 (2003) 114-120
27. Damsky C.H., and Ilic D. Integrin signaling: it's where the action is. Curr Opin Cell Biol 14 (2002) 594-602
28. Kumamoto H., Kimi K., and Ooya K. Detection of cell cycle-related factors in ameloblastomas. J Oral Pathol Med 30 (2001) 309-315
29. Kumamoto H., Kimi K., and Ooya K. Immunohistochemical analysis of apoptosis-related factors (Fas, Fas ligand, caspase-3 and single-stranded DNA) in ameloblastomas. J Oral Pathol Med 30 (2001) 596-602
30. Philipsen H.P., Ormiston I.W., and Reichart P.A. The desmo and osteoplastic ameloblastoma. Histologic variant or clinico-pathologic entity? Case reports. Int J Oral Maxillofac Surg 21 (1992) 352-357
31. Takata T., Miyauchi M., Ogawa I., et al. Immunoexpression of transforming growth factor β in desmoplastic ameloblastoma. Virchows Arch 436 (2000) 319-323
32. Sandra F., Mitsuyasu T., Nakamura N., et al. Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma. Oral Oncol 37 (2001) 193-198
33. Sandra F., Nakamura N., Kanematsu T., et al. The role of MDM2 in the proliferative activity of ameloblastoma. Oral Oncol 38 (2002) 153-157
34. Kumamoto H., and Ooya K. Immunohistochemical and ultrastructural investigation of apoptotic cell death in granular cell ameloblastoma. J Oral Pathol Med 30 (2001) 245-250
35. Okajian G.K., and Schwimmer R. Regulation of epithelial cell surface polarity reversal by β1 integrins. J Cell Sci 107 (1994) 561-576
36. Murata M., Cheng J., Horino K., et al. Enamel proteins and extracellular matrix molecules are co-localized in the pseudocystic stromal space of adenomatoid odontogenic tumor. J Oral Pathol Med 29 (2000) 483-490
37. O'Toole E.A. Extracellular matrix and keratinocyte migration. Clin Exp Dermatol 26 (2001) 525-530
38. Zhang Y., Lu H., Dazin P., et al. Functional differences between integrin alpha4 and alpha5/alphav in modulating the motility of human oral squamous carcinoma cells in response to the V region and heparin-binding domain of fibronectin. Exp Cell Res 295 (2004) 48-58